Addiction & Substance Use Research

Advancing Opioid Addiction Treatment Through Clinical Research

Opioid addiction continues to impact millions of individuals and families across the United States. CenExel partners with sponsors to accelerate innovative research focused on opioid use disorder (OUD), withdrawal management, relapse prevention, and behavioral health support — helping bring safer and more effective treatments to patients in need.

Studies Conducted
0 +
Trial Participants
0 +
Active Sites
0 +
Overview

Leading Opioid Addiction Clinical Research

CenExel provides specialized scientific and operational expertise for opioid addiction and substance use disorder clinical trials. Our experienced teams support studies across early and late-phase development while ensuring compassionate patient care and high-quality data collection.

We work closely with sponsors to improve recruitment, retention, and trial efficiency in addiction-focused research programs.

Conditions Covered

Opioid Addiction Conditions We Research

Our research sites support a broad range of addiction and behavioral health studies focused on opioid dependency, recovery support, and co-occurring psychiatric conditions.

  • Opioid Use Disorder (OUD)
  • Prescription Opioid Dependence
  • Heroin Addiction
  • Withdrawal Management
  • Relapse Prevention
  • Substance Abuse Disorder
  • Co-occurring Anxiety & Depression
  • Chronic Pain & Opioid Dependency
Our Approach

Why Sponsors Choose CenExel for Addiction Research

Our research network provides scientific leadership, rapid enrollment strategies, and operational excellence for opioid addiction and behavioral health clinical studies.

01

Specialized Addiction Expertise

Dedicated investigators experienced in opioid use disorder, behavioral health, and substance dependency studies.

02

Strong Patient Recruitment

Access to diverse patient populations and targeted recruitment strategies for addiction-focused trials.

03

Behavioral Health Experience

Integrated psychiatric and behavioral health support improves retention and patient engagement.

04

End-to-End Trial Support

Comprehensive clinical operations from feasibility and startup through closeout and data delivery.

Phase Coverage

Supported Addiction Research Trial Phases

CenExel supports opioid addiction and substance use disorder clinical trials from first-in-human studies through Phase IV post-market research.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our experienced teams support biomarker strategies, patient engagement, safety monitoring, and regulatory compliance for addiction-related clinical research.

Addiction Task Force

CenExel supports addiction-focused clinical trials with experienced investigators, diverse patient populations, and specialized behavioral health expertise across multiple research sites.

Active Sites

18 Sites

CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg

Our Blog